Q4 2022 Holdings
Filed 2023-02-13 | 47 holdings | $270.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prometheus Biosciences IncPut | COM | 74349U108 | $63.2M | 574,200 | 23.4% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $23.4M | 2,323,000 | 8.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $20.2M | 683,425 | 7.5% |
| Cigna Corp(CI) | COM | 125523100 | $17.4M | 52,611 | 6.4% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $16.4M | 587,836 | 6.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $15.3M | 54,959 | 5.7% |
| Quest Diagnostics Inc(DGX)Put | COM | 74834L100 | $14.4M | 92,000 | 5.3% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $14.0M | 84,399 | 5.2% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $9.9M | 128,000 | 3.7% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $7.6M | 157,129 | 2.8% |
| Icon PLC(ICLR) | SHS | G4705A100 | $6.6M | 33,983 | 2.4% |
| Inogen Inc(INGN) | COM | 45780L104 | $5.7M | 286,692 | 2.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $5.3M | 250,000 | 1.9% |
| Heska Corp(HSKAEUR) | COM RESTRC NEW | 42805E306 | $5.2M | 84,309 | 1.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.7M | 434,635 | 1.8% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $3.5M | 340,000 | 1.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.5M | 555,610 | 1.3% |
| Pharvaris NV(PHVS) | COM | N69605108 | $3.2M | 285,000 | 1.2% |
| Merrimack Pharmaceuticals Inc(MACKEUR) | COM NEW | 590328209 | $2.9M | 250,000 | 1.1% |
| Reata Pharmaceuticals Inc(RETAEUR)Put | CL A | 75615P103 | $2.5M | 67,000 | 0.9% |
| Health Sciences Acquisitions Corp 2 | ORD SHS | G4411D109 | $2.5M | 250,000 | 0.9% |
| Eucrates Biomedical Acquisition Corp. | UNIT 10/23/2027 | G3141W114 | $2.5M | 248,674 | 0.9% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $2.0M | 330,000 | 0.7% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $1.8M | 86,400 | 0.7% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.8M | 1,825,963 | 0.7% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $1.4M | 689,352 | 0.5% |
| Merus NV | COM | N5749R100 | $1.4M | 87,953 | 0.5% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.4M | 3,004,959 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $1.3M | 866,448 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.3M | 70,000 | 0.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.2M | 152,159 | 0.4% |
| Moleculin Biotech Inc | COM | 60855D200 | $1.1M | 1,036,853 | 0.4% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $1.0M | 136,325 | 0.4% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $822.2K | 235,600 | 0.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $821.9K | 235,500 | 0.3% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $820.4K | 260,448 | 0.3% |
| Connect Biopharma Holdings LTD | ADS | 207523101 | $518.7K | 597,678 | 0.2% |
| Sientra Inc | COM | 82621J105 | $517.4K | 2,550,000 | 0.2% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $457.5K | 1,270,758 | 0.2% |
| Elevation Oncology Inc | COM | 28623U101 | $341.7K | 359,731 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $183.3K | 130,000 | 0.1% |
| Caremax Inc | *W EXP 06/08/202 | 14171W103 | $118.9K | 43,549 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $104.1K | 102,049 | 0.0% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $80.4K | 16,110 | 0.0% |
| Humacyte Inc(HUMA) | *W EXP 08/27/202 | 44486Q103 | $20.3K | 49,998 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $19.5K | 38,312 | 0.0% |